STUDY OBJECTIVES: To examine how self-reported ratings of sleep disturbance changed from the time of the simulation visit to four months after the completion of radiation therapy (RT) and to investigate whether specific patient, disease, and symptom characteristics predicted the initial levels of sleep disturbance and/or characteristics of the trajectories of sleep disturbance. DESIGN: Prospective longitudinal study. SETTING: Two radiation therapy centers. PATIENTS: Patients (n = 82) who underwent primary or adjuvant RT for prostate cancer. MEASUREMENTS AND RESULTS: Changes in self-reported sleep disturbance were measured using the General Sleep Disturbance Scale (GSDS). Depressive symptoms were assessed using the Center for Epidemiologic Studies-Depression Scale. Trait and state anxiety were measured using the Spielberger State-Trait Anxiety Inventory. Hierarchical linear modeling was used to answer the study aims. Self-reported sleep disturbance increased during the course of RT and then decreased following the completion of RT. Predictors of higher levels of sleep disturbance included younger age, higher levels of trait anxiety, higher levels of depressive symptoms, and higher levels of sleep disturbance at the initiation of RT. CONCLUSIONS: Sleep disturbance is a significant problem in patients with prostate cancer who undergo RT. Younger men with co-occurring depression and anxiety may be at greatest risk for sleep disturbance during RT.
STUDY OBJECTIVES: To examine how self-reported ratings of sleep disturbance changed from the time of the simulation visit to four months after the completion of radiation therapy (RT) and to investigate whether specific patient, disease, and symptom characteristics predicted the initial levels of sleep disturbance and/or characteristics of the trajectories of sleep disturbance. DESIGN: Prospective longitudinal study. SETTING: Two radiation therapy centers. PATIENTS: Patients (n = 82) who underwent primary or adjuvant RT for prostate cancer. MEASUREMENTS AND RESULTS: Changes in self-reported sleep disturbance were measured using the General Sleep Disturbance Scale (GSDS). Depressive symptoms were assessed using the Center for Epidemiologic Studies-Depression Scale. Trait and state anxiety were measured using the Spielberger State-Trait Anxiety Inventory. Hierarchical linear modeling was used to answer the study aims. Self-reported sleep disturbance increased during the course of RT and then decreased following the completion of RT. Predictors of higher levels of sleep disturbance included younger age, higher levels of trait anxiety, higher levels of depressive symptoms, and higher levels of sleep disturbance at the initiation of RT. CONCLUSIONS:Sleep disturbance is a significant problem in patients with prostate cancer who undergo RT. Younger men with co-occurring depression and anxiety may be at greatest risk for sleep disturbance during RT.
Authors: Christine Miaskowski; Steven M Paul; Bruce A Cooper; Kathryn Lee; Marylin Dodd; Claudia West; Bradley E Aouizerat; Patrick S Swift; William Wara Journal: J Pain Symptom Manage Date: 2008-03-20 Impact factor: 3.612
Authors: Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee Journal: J Am Geriatr Soc Date: 2009-05 Impact factor: 5.562
Authors: Elise L Lev; Lucille Sanzero Eller; Glen Gejerman; John Kolassa; Joan Colella; Janine Pezzino; Patricia Lane; Ravi Munver; Michael Esposito; John Sheuch; Vincent Lanteri; Ihor Sawczuk Journal: Support Care Cancer Date: 2008-08-22 Impact factor: 3.603
Authors: Bradley E Aouizerat; Marylin Dodd; Kathryn Lee; Claudia West; Steven M Paul; Bruce A Cooper; William Wara; Patrick Swift; Laura B Dunn; Christine Miaskowski Journal: Biol Res Nurs Date: 2009-05-05 Impact factor: 2.522
Authors: Marianna Kyranou; Kathleen Puntillo; Laura B Dunn; Bradley E Aouizerat; Steven M Paul; Bruce A Cooper; John Neuhaus; Claudia West; Marylin Dodd; Christine Miaskowski Journal: Cancer Nurs Date: 2014 Nov-Dec Impact factor: 2.592
Authors: Hamza Abid; Kord M Kober; Betty Smoot; Steven M Paul; Marilyn Hammer; Jon D Levine; Kathryn Lee; Fay Wright; Bruce A Cooper; Yvette P Conley; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2017-01-04 Impact factor: 3.612
Authors: Fay Wright; Gail D'Eramo Melkus; Marilyn Hammer; Brian L Schmidt; M Tish Knobf; Steven M Paul; Frances Cartwright; Judy Mastick; Bruce A Cooper; Lee-May Chen; Michelle Melisko; Jon D Levine; Kord Kober; Bradley E Aouizerat; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2015-03-28 Impact factor: 3.612
Authors: Fay Wright; Gail D'Eramo Melkus; Marilyn Hammer; Brian L Schmidt; M Tish Knobf; Steven M Paul; Frances Cartwright; Judy Mastick; Bruce A Cooper; Lee-May Chen; Michelle Melisko; Jon D Levine; Kord Kober; Bradley E Aouizerat; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2015-03-28 Impact factor: 3.612
Authors: Sueann Mark; Janine Cataldo; Anand Dhruva; Steven M Paul; Lee-May Chen; Marilyn J Hammer; Jon D Levine; Fay Wright; Michelle Melisko; Kathryn Lee; Yvette P Conley; Christine Miaskowski Journal: Support Care Cancer Date: 2017-03-09 Impact factor: 3.603
Authors: Fay Wright; Laura B Dunn; Steven M Paul; Yvette P Conley; Jon D Levine; Marilyn J Hammer; Bruce A Cooper; Christine Miaskowski; Kord M Kober Journal: Cancer Nurs Date: 2019 Sep/Oct Impact factor: 2.592
Authors: Marianna Kyranou; Kathleen Puntillo; Bradley E Aouizerat; Laura B Dunn; Steven M Paul; Bruce A Cooper; Claudia West; Marylin Dodd; Charles Elboim; Christine Miaskowski Journal: J Appl Biobehav Res Date: 2014-06